MAM
INFI

Meeder Asset Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Meeder Asset Management’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-3,488
Closed -$4K – 2460
2019
Q3 		$4K Buy
3,488
+1,242
+55% +$1.69K ﹤0.01% 1844
2019
Q2 		$4K Hold
2,246
– – ﹤0.01% 1757
2019
Q1 		$4K Buy
2,246
+485
+28% +$710 ﹤0.01% 1460
2018
Q4 		$2K Sell
1,761
-783
-31% -$1.41K ﹤0.01% 1592
2018
Q3 		$7K Buy
2,544
+1,026
+68% +$2.12K ﹤0.01% 1261
2018
Q2 		$2.9K Buy
1,518
+249
+20% +$503 ﹤0.01% 1363
2018
Q1 		$3K Buy
1,269
+275
+28% +$589 ﹤0.01% 1340
2017
Q4 		$2K Sell
994
-1,644
-62% -$3.41K ﹤0.01% 1520
2017
Q3 		$4K Buy
2,638
+1,448
+122% +$1.8K ﹤0.01% 1339
2017
Q2 		$2K Buy
1,190
+755
+174% +$1.46K ﹤0.01% 1449
2017
Q1 		$1K Sell
435
-7,703
-95% -$19K ﹤0.01% 1580
2016
Q4 		$11K Buy
+8,138
New +$10.6K ﹤0.01% 745

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Meeder Asset Management's INFI Position: Q4 2019 in Review

Meeder Asset Management sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q4 2019, closing a stake of 3,488 shares — an estimated $4K sold.

Meeder Asset Management first reported a position in INFI in Q4 2016 and held it in 12 quarters. The position peaked at $11K in Q4 2016. 47 funds tracked by Wall St. Rank hold INFI as of Q4 2019.

  • Meeder Asset Management reported no remaining Infinity Pharmaceuticals, Inc. position as of Q4 2019 after selling out during the quarter.
  • Meeder Asset Management sold 3,488 Infinity Pharmaceuticals, Inc. shares in Q4 2019, an estimated $4K.
  • Meeder Asset Management first reported a position in Infinity Pharmaceuticals, Inc. in Q4 2016 and held it in 12 quarters.
  • Meeder Asset Management's Infinity Pharmaceuticals, Inc. position peaked at $11K in Q4 2016.
  • 47 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2019.

Based on Meeder Asset Management's 13F filing for Q4 2019, filed 13 Feb 2020.